Topic: Tumor Size is Defining Factor in experimental immunotherapy drug

Anti-PD-1 Antibody MK-3475 tested in Melanoma patients - less robust response with larger tumors.   Further research is required and how this finding crosses over to CCA patients is yet to be determined:
http://newsnetwork.mayoclinic.org/discu … Id=8554532

THIS INFORMATION IS NOT INTENDED NOR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROVIDER

Re: Tumor Size is Defining Factor in experimental immunotherapy drug

Thanks for that Marion.

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.